11-118257298-C-G

Variant summary

Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong

The NM_005797.4(MPZL2):ā€‹c.600G>Cā€‹(p.Arg200Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000137 in 1,459,034 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā˜…).

Frequency

Genomes: not found (cov: 32)
Exomes š‘“: 0.0000014 ( 0 hom. )

Consequence

MPZL2
NM_005797.4 missense

Scores

5
14

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: -0.0430
Variant links:
Genes affected
MPZL2 (HGNC:3496): (myelin protein zero like 2) Thymus development depends on a complex series of interactions between thymocytes and the stromal component of the organ. Epithelial V-like antigen (EVA) is expressed in thymus epithelium and strongly downregulated by thymocyte developmental progression. This gene is expressed in the thymus and in several epithelial structures early in embryogenesis. It is highly homologous to the myelin protein zero and, in thymus-derived epithelial cell lines, is poorly soluble in nonionic detergents, strongly suggesting an association to the cytoskeleton. Its capacity to mediate cell adhesion through a homophilic interaction and its selective regulation by T cell maturation might imply the participation of EVA in the earliest phases of thymus organogenesis. The protein bears a characteristic V-type domain and two potential N-glycosylation sites in the extracellular domain; a putative serine phosphorylation site for casein kinase 2 is also present in the cytoplasmic tail. Two transcript variants encoding the same protein have been found for this gene. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Likely_benign. Variant got -2 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.0516479).

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
MPZL2NM_005797.4 linkuse as main transcriptc.600G>C p.Arg200Ser missense_variant 5/6 ENST00000278937.7 NP_005788.1 O60487A0A024R3K1
MPZL2NM_144765.3 linkuse as main transcriptc.600G>C p.Arg200Ser missense_variant 5/5 NP_658911.1 O60487A0A024R3K1

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
MPZL2ENST00000278937.7 linkuse as main transcriptc.600G>C p.Arg200Ser missense_variant 5/61 NM_005797.4 ENSP00000278937.2 O60487
MPZL2ENST00000438295.2 linkuse as main transcriptc.600G>C p.Arg200Ser missense_variant 5/51 ENSP00000408362.2 O60487
MPZL2ENST00000528554.1 linkuse as main transcriptn.363G>C non_coding_transcript_exon_variant 1/23
MPZL2ENST00000534175.6 linkuse as main transcriptn.648G>C non_coding_transcript_exon_variant 4/55

Frequencies

GnomAD3 genomes
Cov.:
32
GnomAD4 exome
AF:
0.00000137
AC:
2
AN:
1459034
Hom.:
0
Cov.:
29
AF XY:
0.00000138
AC XY:
1
AN XY:
725718
show subpopulations
Gnomad4 AFR exome
AF:
0.00
Gnomad4 AMR exome
AF:
0.00
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.00
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
0.00
Gnomad4 OTH exome
AF:
0.0000332
GnomAD4 genome
Cov.:
32

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

Inborn genetic diseases Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingAmbry GeneticsFeb 28, 2023The c.600G>C (p.R200S) alteration is located in exon 5 (coding exon 5) of the MPZL2 gene. This alteration results from a G to C substitution at nucleotide position 600, causing the arginine (R) at amino acid position 200 to be replaced by a serine (S). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.14
BayesDel_addAF
Uncertain
0.052
T
BayesDel_noAF
Benign
-0.16
CADD
Benign
14
DANN
Uncertain
0.98
DEOGEN2
Benign
0.074
T;T
Eigen
Benign
-0.71
Eigen_PC
Benign
-0.62
FATHMM_MKL
Benign
0.11
N
LIST_S2
Benign
0.58
.;T
M_CAP
Benign
0.012
T
MetaRNN
Benign
0.052
T;T
MetaSVM
Uncertain
-0.053
T
MutationAssessor
Benign
1.6
L;L
PrimateAI
Benign
0.34
T
PROVEAN
Benign
0.15
N;N
REVEL
Benign
0.27
Sift
Uncertain
0.0080
D;D
Sift4G
Uncertain
0.023
D;D
Polyphen
0.0
B;B
Vest4
0.17
MutPred
0.21
Loss of sheet (P = 0.0084);Loss of sheet (P = 0.0084);
MVP
0.34
MPC
0.062
ClinPred
0.46
T
GERP RS
0.82
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.1
Varity_R
0.083
gMVP
0.24

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.040
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

No publications associated with this variant yet.

Other links and lift over

hg19: chr11-118128013; API